@pathtights40
Active 6 months, 2 weeks ago
Eltrombopag, a thrombopoietin receptor agonist, may increase platelet is important throughout thrombocytopenic people. We performed a new stage Two examine, adaptively randomizing patients with ≥35 days post-HSCT for placebo as well as eltrombopag in a platelet depend ≤20,000/µL regarding 1 week as well as platelet transfusion-dependent plus […] View
Sorry, there was no activity found. Please try a different filter.
